The satiety challenge tackled with peptides from DNF-10 - New data
07/05/2024
The satiety challenge tackled with peptides from DNF-10 - New data
DNF-10 is a hydrolysate fraction from Saccharomyces cerevisiae, which acts on the gut-brain mediators of satiety, to lower calorie intake and reduce body fat mass.
NEW DATA - CHARACTERISATION OF PEPTIDES & BIOACTIVE POTENTIAL
New research on the characterisation of the active fraction of DNF-10 has been conducted: composition in amino acids, sequencing of peptides, molecular size distribution, digestion to emphasis the bioactive sequences.
DNF-10 has the potential to release sequences inhibiting DPP-4, an enzyme proven to contribute to the degradation of GLP-1.
DNF-10 has the potential to release sequences inhibiting DPP-4, an enzyme proven to contribute to the degradation of GLP-1.
Visit our stand H106 to discover the link between these new data and the satiety effect provided with DNF-10.
DISCOVER THE RESULTS AT VITAFOODS
CLINICALLY PROVEN BENEFITS
- Patented ingredient
- Demonstrated mechanism of action: gut-brain axis moderation of the appetite
- Significant reduction of calorie intake after first weeks of supplementation
- Significant weight loss after the first month
- The weight lost is from fat mass
- Abdominal fat and waist circumference decrease significantly
This website is intended to provide information about Fytexia’s ingredients, used in various food/dietary supplement products around the world. It is only intended for business to business and to provide information to food/dietary supplement professionals and is not designed for the general public. Statements used on this website have not been evaluated by the Food and Drug Administration or any other competent authority. Products are not intended to diagnose, treat, cure or prevent any disease.
